The role of Blastocystis hominis (BH) as a pathogen in the human body is shrouded in controversy. Very commonly found in society, this mysterious and elusive parasite still baffles scientific and medical communities. Having an understanding of what is currently known about the BH microbe, and being aware of the use of non-pharmaceutical measures, will guide many therapists towards safe and effective individual protocols, where treatment, regardless of symptom status, can increase overall health and wellbeing.
A look at the first study to evaluate tubulin as a target of curcumin against Giardia trophozoites.
Alessandra covers off important areas of naturopathic care in paediatric cases, from safety considerations and assessment techniques to navigating the palatability of treatments and working effectively with their doctors and parents.
In this clinically-focussed workshop, gastrointestinal expert Alessandra Edwards will share with you the latest research and therapeutic approach to diagnose and treat small intestinal bacterial overgrowth (SIBO) and parasites such as Blastocystis hominis and Dientamoeba fragilis.
Though Blastocystis hominis and Dientamoeba fragilis are being increasingly detected in patients with unresolved gut disorders, the jury is still out on whether intervention is medically necessary.
In this podcast we're joined by Helen Padarin, who shares her valuable clinical expertise treating infections, biofilms and gut imbalances.
Challenging the status quo of whether a parasite is a "friend" or a "foe". We welcome back Mike Ash to explore the immunological impact of parasites.
Dr Mark Donohoe discusses the importance of gastrointestinal microbiome biodiversity for optimal health and wellbeing outcomes in our patients.